We are live on
!
Find out more
Federated Hermes Portfolio holdings
AUM
$69.6B
1-Year Est. Return
42.52%
This Fund
S&P 500
This Quarter
Est. Return
+6.3%
1 Year Est. Return
+42.52%
3 Year Est. Return
+132.48%
5 Year Est. Return
+152.58%
10 Year Est. Return
+652.43%
AUM
$31.9B
AUM Growth
+$1.95B
(+6.5%)
Cap. Flow
+$433M
Cap. Flow
% of AUM
1.36%
Top 10 Holdings %
Top 10 Hldgs %
19.72%
Holding
2,075
New
328
Increased
694
Reduced
841
Closed
117
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Illumina
ILMN
|
+$152M |
| 2 |
Ventas
VTR
|
+$139M |
| 3 |
Williams Companies
WMB
|
+$122M |
| 4 |
Healthpeak Properties
DOC
|
+$100M |
| 5 |
Chevron
CVX
|
+$78.1M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AstraZeneca
AZN
|
+$276M |
| 2 |
ESRX
Express Scripts Holding Company
ESRX
|
+$110M |
| 3 |
Fortune Brands Innovations
FBIN
|
+$84.2M |
| 4 |
AGN
Allergan Inc
AGN
|
+$73.4M |
| 5 |
Morgan Stanley
MS
|
+$66.1M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 15.93% |
| 2 | Consumer Staples | 12.47% |
| 3 | Energy | 12.35% |
| 4 | Financials | 8.98% |
| 5 | Utilities | 8.39% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1101
Jazz Pharmaceuticals
JAZZ
$15.8B
| $1.32M | ﹤0.01% |
9,000
-45,187
| -83% | -$6.27M |
|
|
VRE
1102
DELISTED
Veris Residential
VRE
| $1.31M | ﹤0.01% |
61,144
-1,431
| -2% | -$30.2K |
|
1103
Ligand Pharmaceuticals
LGND
$5.49B
| $1.31M | ﹤0.01% |
33,775
+15,639
| +86% | +$635K |
|
1104
Murphy USA
MUSA
$9.43B
| $1.31M | ﹤0.01% |
26,717
-3,086
| -10% | -$143K |
|
|
BID
1105
DELISTED
Sotheby's
BID
| $1.31M | ﹤0.01% |
31,104
-15,833
| -34% | -$645K |
|
|
ASNA
1106
DELISTED
Ascena Retail Group, Inc.
ASNA
| $1.3M | ﹤0.01% |
3,816
+1,053
| +38% | +$360K |
|
|
X
1107
DELISTED
US Steel
X
| $1.3M | ﹤0.01% |
50,076
+16,438
| +49% | +$420K |
|
|
CNW
1108
DELISTED
CON-WAY INC.
CNW
| $1.3M | ﹤0.01% |
25,795
+1,357
| +6% | +$60.9K |
|
1109
Itron
ITRI
$4.03B
| $1.3M | ﹤0.01% |
31,987
+16,468
| +106% | +$627K |
|
1110
Medifast
MED
$134M
| $1.29M | ﹤0.01% |
42,483
-825
| -2% | -$25.7K |
|
1111
American Airlines Group
AAL
$8.41B
| $1.29M | ﹤0.01% |
30,000
-71,683
| -70% | -$2.8M |
|
|
MZTI
1112
The Marzetti Company
MZTI
$2.81B
| $1.28M | ﹤0.01% |
13,448
+1,889
| +16% | +$175K |
|
1113
Cummins
CMI
$72.6B
| $1.28M | ﹤0.01% |
8,287
-249,546
| -97% | -$37.8M |
|
1114
Cheesecake Factory
CAKE
$4.83B
| $1.27M | ﹤0.01% |
27,354
-3,097
| -10% | -$143K |
|
1115
Vanguard FTSE All-World ex-US ETF
VEU
$68.9B
| $1.26M | ﹤0.01% |
24,050
| – | – |
|
1116
Jack in the Box
JACK
$253M
| $1.26M | ﹤0.01% |
21,013
+12,484
| +146% | +$716K |
|
|
ANDV
1117
DELISTED
Andeavor
ANDV
| $1.25M | ﹤0.01% |
21,396
+3,664
| +21% | +$202K |
|
|
PARA
1118
DELISTED
Paramount Global Class B
PARA
| $1.25M | ﹤0.01% |
20,157
-32,161
| -61% | -$1.91M |
|
1119
Aflac
AFL
$58.6B
| $1.25M | ﹤0.01% |
40,190
-15,998
| -28% | -$499K |
|
1120
Jabil
JBL
$31.1B
| $1.25M | ﹤0.01% |
59,821
-3,243
| -5% | -$60.3K |
|
1121
Zions Bancorporation
ZION
$9.56B
| $1.25M | ﹤0.01% |
42,406
-5,665
| -12% | -$167K |
|
|
HMSY
1122
DELISTED
HMS Holdings Corp.
HMSY
| $1.25M | ﹤0.01% |
61,171
-737
| -1% | -$13.3K |
|
1123
VF Corp
VFC
$5B
| $1.24M | ﹤0.01% |
20,959
+5,762
| +38% | +$335K |
|
|
CLVS
1124
DELISTED
Clovis Oncology, Inc.
CLVS
| $1.24M | ﹤0.01% |
30,000
+10,000
| +50% | +$515K |
|
|
AF
1125
DELISTED
Astoria Financial Corporation
AF
| $1.24M | ﹤0.01% |
92,318
+1,822
| +2% | +$24.2K |
|
Similar funds
Federated Hermes's Q2 2014 Portfolio in Review
As of Q2 2014, Federated Hermes held 2,075 positions worth $31.9B, up 6.5% from $29.9B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
Federated Hermes's Q2 2014 filing shows 328 new, 694 increased, 841 reduced and 117 closed positions. Its largest new stake was ATHLON ENERGY INC COM: 939,555 shares worth $44.8M. The largest sale was AstraZeneca, an estimated $276M.
By sector, the portfolio is most concentrated in Healthcare at 16% of assets, down from 17% a quarter earlier, followed by Consumer Staples and Energy.
- Federated Hermes's largest Q2 2014 buy was ATHLON ENERGY INC COM: 939,555 shares worth $44.8M.
- Federated Hermes added most to Illumina in Q2 2014, an estimated $152M increase.
- Federated Hermes's biggest Q2 2014 reduction was AstraZeneca, cutting an estimated $276M.
- Federated Hermes fully exited SIEMENS AKTIENGESELLSCHAFT ADS in Q2 2014, selling an estimated $39.7M.
- Federated Hermes's ten largest holdings make up 20% of its $31.9B portfolio in Q2 2014.
- Federated Hermes opened 328 new positions and closed 117 in Q2 2014.
- Federated Hermes's portfolio value rose 6.5% quarter-over-quarter to $31.9B.
Based on Federated Hermes's 13F filing for Q2 2014, filed 7 Aug 2014.